“Medication Overload” is a growing issue, especially among older adults. On Tuesday, September 24, 2019, Dr. Ilene Harris will discuss polypharmacy and its implications at an event hosted by Aging2.0 Baltimore. She will share insights from IMPAQ’s work leading research and evaluations that improve medication use and pharmaceutical policy decision making.
Dr. Harris will be joined by Dr. Nicole Brandt of the University of Maryland School of Pharmacy and Dr. Michelle Fritsch of Retirement Wellness Strategies.
IMPAQ is a sponsor of this event. More information is available on the Aging2.0 website.
About Dr. Harris
Ilene Harris, PharmD, PhD is Vice President and Chief Research Officer at IMPAQ International. She provides strategic leadership and technical oversight of the IMPAQ Pharmaceutical Health Services Practice Area. Dr. Harris is a nationally recognized researcher with deep understanding of chronic disease management, pharmacoepidemiology, drug policy, and medication use and quality.
Aging2.0 strives to accelerate innovation to address the biggest challenges and opportunities in aging. Aging2.0’s international, interdisciplinary and intergenerational community has grown to 40k+ innovators across 20+ countries.